Europe · Wires & real time · Reuters

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Published by Reuters · United Kingdom 9 h ago

Novo Nordisk's ‌Wegovy weight-loss pill beat third-quarter sales forecasts and the drug maker lifted its full-year outlook again on Wednesday, boosting efforts to regain lost…

Read the full article on Reuters Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

Anadolu Agency

Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts

Share

Also worth reading

Eurozone negotiated wage growth to accelerate slightly in early 2027: ECB

CSTO may weigh invoking Article 25 of its charter against Armenia — chief

Revolut's rise to become Europe's $115 billion big bank rival

Democrat Andrews' South Carolina midterm victory defies prediction markets odds

BMW tune-up fixes today’s problem not tomorrow’s

Markets recover after lows as Democrats sweep House and Senate